Role of the nitric oxide/cyclic GMP pathway and ascorbic acid in 3-morpholinosydnonimine (SIN-1)-induced increases in dopamine secretion from PC12 cells. A microdialysis in vitro study

Neuroscience Letters

Volumn 353, Issue 1, 2003, Pages 5-8

  Serra, Pier Andrea ^a   Migheli, Rossana ^a   Rocchitta, Gaia ^a   Taras, Maria G ^a   Mura, Maria P ^a   Delogu, Maria R ^a   Esposito, Giovanni ^a   Desole, Maria S ^a   Miele, Egidio ^a   Miele, Maddalena ^a,b  

^a UNIVERSITY OF SASSARI   (Italy)

^b NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

Calcium dopamine secretion; Cyclic GMP; Nitric oxide; PC12 cell

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 3 O METHYLDOPAMINE; ASCORBIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM ION; CYCLIC GMP; DOPAMINE; GUANYLATE CYCLASE INHIBITOR; LINSIDOMINE; NIFEDIPINE; NITRIC OXIDE; PEROXYNITRITE; POTASSIUM ION;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DIALYSATE; DOPAMINE RELEASE; MICRODIALYSIS; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT; SOLUBILITY;

EID: 10744232326     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.07.022     Document Type: Article

References (11)

1. Armstrong C.M., Hille B. Voltage-gated ion channels and electrical excitability. Neuron. 20:1998;371-380.
2. Daveu C., Servy C., Dendane M., Marin P., Ducrocq C. Oxidation and nitration of catecholamines by nitrogen oxides derived from nitric oxide. Nitric Oxide. 1:1997;234-243.
3. Ischiropoulos H., Duran D., Horwitz J. Peroxynitrite-mediated inhibition of DOPA synthesis in PC12 cells. J. Neurochem. 65:1995;2366-2372.
4. Jackson T.S., Xu A., Vita J.A., Keaney J.F. Jr. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ. Res. 83:1998;916-922.
5. Keynes R.G., Griffiths C., Garthwaite J. Superoxide-dependent consumption of nitric oxide in biological media may confound in vitro experiments. Biochem. J. 369:2003;399-406.
6. Knowles R.G., Palacios M., Palmer R.M., Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. USA. 86:1989;5159-5162.
7. Milbourne E.A., Bygrave F.L. Do nitric oxide and cGMP play a role in calcium cycling? Cell Calcium. 18:1995;207-213.
8. Serra P.A., Rocchitta G., Delogu M.R., Migheli R., Taras M.G., Mura M.P., Esposito G., Miele E., Desole M.S., Miele M. Role of the nitric oxide/cyclic GMP pathway and extracellular environment in the nitric oxide donor-induced increase in dopamine secretion from PC12. J. Neurochem. 86:2003;1403-1413.
9. Serra P.A., Rocchitta G., Esposito G., Delogu M.R., Migheli R., Miele E., Desole M.S., Miele M. A study on the role of nitric oxide and iron in 3-morpholino-sydnonimine-induced increases in dopamine release in the striatum of freely moving rats. Br. J. Pharmacol. 134:2001;275-282.
10. West A.R., Galloway M.P., Grace A.A. Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms. Synapse. 44:2002;227-245.
11. Wink D.A., Mitchell J.B. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med. 25:1998;434-456.